Emily Bagby
Physician Assistant · Frederick, MDNPI 1720277270
Payments from drug & device makers
Across 67 payments — averaging $20.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$558
- AbbVie$118
- Amgen$116
- Seqirus USA Inc$77
- Astellas Pharma US Inc$64
- Dexcom, Inc.$60
- plus $406 from 14 others
What the payments were for
- Food & beverage$1,38699%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $558 |
| AbbVie | 6 | $118 |
| Amgen | 7 | $116 |
| Seqirus USA Inc | 5 | $77 |
| Astellas Pharma US Inc | 3 | $64 |
| Dexcom, Inc. | 1 | $60 |
| Lilly USA, LLC | 3 | $51 |
| Jazz Pharmaceuticals Inc. | 3 | $45 |
| Biohaven Pharmaceuticals, Inc. | 2 | $45 |
| GSK | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Merck | 2 | $32 |
| Sanofi Pasteur Inc. | 2 | $30 |
| Exact Sciences | 1 | $29 |
| AstraZeneca | 2 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $13 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$114
How this compares
$1,398 in reported general payments places this provider in the 80th percentile of 2,567 physician assistant providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $20,662 |
| MounjaroTirzepatide | 18 | $18,052 |
| JanuviaSitagliptin Phosphate | 11 | $11,581 |
| Atorvastatin Calcium | 128 | $1,520 |
| SynthroidLevothyroxine Sodium | 32 | $1,137 |
| Duloxetine Hcl | 27 | $1,028 |
| Gabapentin | 37 | $917 |
| Famotidine | 22 | $764 |
| Olmesartan Medoxomil | 28 | $745 |
| Pantoprazole Sodium | 24 | $701 |
| Levothyroxine Sodium | 47 | $693 |
| Lansoprazole | 11 | $678 |
| Metoprolol Succinate | 44 | $632 |
| Tamsulosin Hcl | 23 | $595 |
| Amlodipine Besylate | 94 | $594 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $51 | $18,05218 claims |
| MerckJanuvia | $32 | $11,58111 claims |
| AbbVieSynthroid | $118 | $1,13732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,567 physician assistant providers in Maryland.
Other physician assistant in Frederick
- Jinhui YuanFrederick$21K
- Heather DemoryFrederick$12K
- Jessie MallalieuFrederick$10K
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Michael RitmillerOwings Mills$92K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Brittany YerkesSalisbury$81K
- Bruce SmithBaltimore$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.